Epigenetic mechanisms and drug discovery in rheumatology
David F Tough, Rab K Prinjha and Paul P Tak
DOI: https://doi.org/10.7861/clinmedicine.15-6-s64
Clin Med December 2015 David F Tough
AEpigenetics DPU, Immuno-inflammation Therapy Area, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK;
Roles: principal scientific investigator
Rab K Prinjha
BEpigenetics DPU, Immuno-inflammation Therapy Area Unit, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK;
Roles: vice president and head
Paul P Tak
CImmuno-inflammation Therapy Area Unit, GlaxoSmithKline, Medicines Research Centre, Stevenage, UK
Roles: senior vice president and head
Article Tools
Epigenetic mechanisms and drug discovery in rheumatology
David F Tough, Rab K Prinjha, Paul P Tak
Clinical Medicine Dec 2015, 15 (Suppl 6) s64-s71; DOI: 10.7861/clinmedicine.15-6-s64
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.